FIGURE 2
The nanotechnology provides extensive and effective nanomaterials and tools that could be used in the detection and treatment of different inflammatory disorders and conditions. Some in vitro andin vivo experiments have been performed to examine the impact of nanoparticles on the development of inflammation and its subsequent disorders (Kadhim, Karsh, & Jabir, 2020). By modulating the nanoparticles, they can be directed to pass from the metabolic barriers and deliver drugs to particular targets without interacting with other cells. This makes them promising therapeutical candidates as anti-aging drugs that exert their effect by limiting the local inflammation.
In spite of the therapeutic potential of bioactive nanoparticles in the treatment of diseases initiated by chronic inflammation, still, further studies are required to overcome their potential toxicity and identify their pharmacokinetic properties, such as the least effective concentrations, physicochemical interactions, route of administration, etc. (Elsayed & Norredin, 2019). New advances in nanotechnology and nanomedicine-based strategies have led to the emergence of nanomedicine for the inflammatory disease treatments that can be directly effective in delaying aging (Table 6 ) (Rizzuto et al., 2019).